Completed NA INTERVENTIONAL 2-arm NCT01236807

MR INFORM - MR Perfusion Imaging to Guide Management of Patients With Stable Coronary Artery Disease

MR INFORM - a Randomized Non-inferiority Multicenter Trial Comparing MR Perfusion Imaging and Fractional Flow Reserve (FFR) to Guide Management of Patients With Stable Coronary Artery Disease

Sponsor: Bayer

Conditions Coronary Artery Disease Myocardial Ischaemia Stable Angina

Interventions FFR guidance MR perfusion guidance

Updated 6 times since 2017 Last updated: Jun 21, 2022 Started: Dec 31, 2010 Primary completion: Aug 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Coronary Artery Disease and Myocardial Ischaemia and is currently completed. Bayer leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jul 2022 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Jul 2022 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Dec 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bayer
Guy's and St Thomas' NHS Foundation Trust
King's College London

Data source: King's College London

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom